The biology of interferon actions

[1]  P. Strevens.  Iii , 1985, Middle Egyptian.

[2]  A. Inglot.  The hormonal concept of interferon , 2005, Archives of Virology.

[3]  H. Kirchner,et al.  The effect of interferons on cellular differentiation , 1986, Blut.

[4]  H. Kirchner.  Interferons, a group of multiple lymphokines , 2004, Springer Seminars in Immunopathology.

[5]  D. Niederwieser,et al.  Interferons (IFNs) and tumor necrosis factors (TNFs) in T cell-mediated immune responses against alloantigens. I. Influence on the activation of resting and antigen-primed T cells. , 1988, Immunobiology.

[6]  P. Lengyel,et al.  Double-stranded RNA and interferon action. , 1987, Journal of interferon research.

[7]  P. Sehgal,et al.  Human Interferon-β2 , 1987 .

[8]  O. Dapunt,et al.  Human interferon-gamma increases adhesion of cultured carcinoma cells to the substratum. , 1987, Cancer letters.

[9]  M. Rubinstein,et al.  Multiple interferon subtypes: the phenomenon and its relevance. , 1987, Journal of interferon research.

[10]  I. kerr.  The 2-5A system: a personal view. , 1987, Journal of interferon research.

[11]  G. Nossal.  The Basic Components of the Immune System , 1987 .

[12]  W. Fiers,et al.  B cell growth modulating and differentiating activity of recombinant human 26‐kd protein (BSF‐2, HuIFN‐beta 2, HPGF). , 1987, The EMBO journal.

[13]  J. Vilček,et al.  A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1 , 1987, Molecular and cellular biology.

[14]  F. Sigaux,et al.  Absence of interferon- receptors on hairy cells from a patient resistant to interferon- therapy , 1987 .

[15]  A. Kimchi,et al.  Autocrine β-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation , 1986, Cell.

[16]  P. Sehgal,et al.  Induction of β 2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation , 1986, Cell.

[17]  Herberman Rb.  Effects of biological response modifiers on effector cells with cytotoxic activity against tumors. , 1986 .

[18]  T. Maniatis,et al.  Detection of factors that interact with the human β-interferon regulatory region in vivo by DNAase I footprinting , 1986, Cell.

[19]  B. Beutler,et al.  Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.

[20]  K. Foon,et al.  Relationship of the clinical response and binding of recombinant interferon alpha in patients with lymphoproliferative diseases. , 1986, Blood.

[21]  H. Ozer,et al.  B cell growth factor-induced proliferation of hairy cell lymphocytes and inhibition by type I interferon in vitro. , 1986, Blood.

[22]  F. Sigaux,et al.  Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells , 1986 .

[23]  D. Goeddel,et al.  Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. , 1986, Nature.

[24]  R. Herberman.  Effects of biological response modifiers on effector cells with cytotoxic activity against tumors. , 1986, Seminars in oncology.

[25]  J. Trill,et al.  The gene for the human immune interferon receptor is located on chromosome 6. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Wong,et al.  Tumour necrosis factors α and β inhibit virus replication and synergize with interferons , 1986, Nature.

[27]  C. Stiles,et al.  Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells , 1985, Cell.

[28]  A. Kimchi,et al.  Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Richard Treisman,et al.  Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences , 1985, Cell.

[30]  J. Gutterman,et al.  Down‐regulation of peripheral blood cell interferon receptors in chronic myelogenous leukemia patients undergoing human interferon (HuIFNα) therapy , 1985, International journal of cancer.

[31]  G. Stark,et al.  α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences , 1985, Nature.

[32]  G. Trinchieri,et al.  Immune interferon: a pleiotropic lymphokine with multiple effects. , 1985, Immunology today.

[33]  M. Clemens,et al.  Regulation of cell proliferation and differentiation by interferons. , 1985, The Biochemical journal.

[34]  A. Kimchi,et al.  Close link between reduction of c-myc expression by interferon and G0/G1 arrest , 1985, Nature.

[35]  S. Carrel,et al.  Recombinant interferon‐γ can induce the expression of HLA‐DR and ‐DC on DR‐negative melanoma cells and enhance the expression of HLA‐ABC and tumor‐associated antigens , 1985 .

[36]  T. Bonner,et al.  Genes and gene products involved in growth regulation of tumor cells. , 1985, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[37]  M. Clemens.  Interferons and oncogenes. , 1985, Nature.

[38]  S. Carrel,et al.  Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens. , 1985, European journal of immunology.

[39]  K. Frei,et al.  [Interleukin 1]. , 1985, Schweizerische medizinische Wochenschrift.

[40]  G. Stark,et al.  Induction of human mRNAs by interferon. , 1984, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[41]  S. Pestka,et al.  Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment. , 1984, Cancer research.

[42]  C. Baglioni,et al.  Interferon is a polypeptide hormone. , 1984, Microbiological sciences.

[43]  E. Knight,et al.  Selective reduction of c-myc mRNA in Daudi cells by human beta interferon. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[44]  B. Rouse,et al.  Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. , 1984, Science.

[45]  K. Zoon,et al.  Studies of the interferon receptors. , 1984, Pharmacology & therapeutics.

[46]  G. Sen.  Biochemical pathways in interferon-action. , 1984, Pharmacology & therapeutics.

[47]  H. Varmus.  The molecular genetics of cellular oncogenes. , 1984, Annual review of genetics.

[48]  G. Trinchieri,et al.  Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway , 1983, The Journal of experimental medicine.

[49]  D. Cantrell,et al.  Transient expression of interleukin 2 receptors. Consequences for T cell growth , 1983, The Journal of experimental medicine.

[50]  M. Willingham,et al.  Human interferon alpha enters cells by receptor-mediated endocytosis. , 1983, Virology.

[51]  C. Nathan,et al.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.

[52]  D. Katz,et al.  Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon. , 1983, Journal of immunology.

[53]  E. Rozengurt.  Growth factors, cell proliferation and cancer: an overview. , 1983, Molecular biology & medicine.

[54]  E. Maeyer,et al.  Delayed hypersensitivity to Newcastle disease virus in high and low interferon-producing mice. , 1983 .

[55]  W. Paul,et al.  Regulation of B-cell growth and differentiation by soluble factors. , 1983, Annual review of immunology.

[56]  M. Aguet,et al.  Interferon receptors. , 1983, Interferon.

[57]  T. Nilsen,et al.  Mechanisms of antiviral action of interferon. , 1983, Interferon.

[58]  C. Baglioni,et al.  Down-regulation of the interferon receptor. , 1982, The Journal of biological chemistry.

[59]  M. Fellous,et al.  Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells , 1982, Nature.

[60]  T. Shows,et al.  Clustering of leukocyte and fibroblast interferon genes of human chromosome 9. , 1982, Science.

[61]  C. Epstein,et al.  Direct evidence that the gene product of the human chromosome 21 locus, IFRC, is the interferon-alpha receptor. , 1982, Biochemical and biophysical research communications.

[62]  T. Aune,et al.  Activation of a suppressor T-cell pathway by interferon. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Lengyel.  Biochemistry of interferons and their actions. , 1982, Annual review of biochemistry.

[64]  M. Aguet,et al.  High affinity binding of 125I-Labeled mouse interferon to a specific cell surface receptor. II. Analysis of binding properties. , 1981, Virology.

[65]  M. Aguet,et al.  Specific high-affinity binding of 125I-labeled mouse interferon to interfevon resistant embryonal carcinoma cells in vitro. , 1981, Virology.

[66]  R. Welsh,et al.  Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells. , 1981, Journal of immunology.

[67]  J. Weissenbach,et al.  Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[68]  C. Rochette-Egly,et al.  THE EFFECT OF INTERFERON ON CYCLIC NUCLEOTIDES * , 1980, Annals of the New York Academy of Sciences.

[69]  E. Wang,et al.  Interferon effects on microfilament organization cellular fibronectin distribution, and cell motility in human fibroblasts , 1980, The Journal of cell biology.

[70]  T. Nilsen,et al.  Mechanism for discrimination between viral and host mRNA in interferon-treated cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[71]  C. Samuel,et al.  Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[72]  W. Stewart.  Mechanisms of Antiviral Actions of Interferons , 1979 .

[73]  P. Lengyel,et al.  Interferon, double-stranded RNA, and protein phosphorylation. Characteristics of a double-stranded RNA-activated protein kinase system partially purified from interferon treated Ehrlich ascites tumor cells. , 1978, The Journal of biological chemistry.

[74]  I. Gresser,et al.  Enhanced NK cell activity in mice injected with interferon and interferon inducers , 1978, Nature.

[75]  R. Friedman.  Antiviral activity of interferons. , 1977, Bacteriological reviews.

[76]  R. Desrosiers,et al.  Impairment of reovirus mRNA methylation in extracts of interferon-treated Ehrilich ascites tumor cells: further characteristics of the phenomenon , 1977, Journal of virology.

[77]  R. Donahoe,et al.  Interferon preparations enhance phagocytosis in vivo , 1976, Infection and immunity.

[78]  I. Gresser,et al.  Interferon and cell division. IX. Interferon-resistant L1210 cells: characteristics and origin. , 1974, Journal of the National Cancer Institute.

[79]  I. Gresser,et al.  Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells. , 1972, Nature: New biology.

[80]  I. Gresser,et al.  Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[81]  K. Cantell,et al.  Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells. , 1962, Virology.

[82]  J. Lindenmann,et al.  Virus interference. I. The interferon. , 1987, Proceedings of the Royal Society of London. Series B, Biological sciences.